Cargando…
Erectile dysfunction therapy in countries where implant is economically not feasible
Erectile dysfunction (ED), a frequent complaint in the primary care setting, is strongly associated with obesity, cigarette smoking and other common cardiovascular risk factors like hypertension, diabetes mellitus (DM), lipid disorders and the metabolic syndrome. The prevalence of these cardiovascul...
Autores principales: | Garza-Gangemi, Adrián M., Sotomayor-de Zavaleta, Mariano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422700/ https://www.ncbi.nlm.nih.gov/pubmed/28540224 http://dx.doi.org/10.21037/tau.2017.04.15 |
Ejemplares similares
-
Neurogenic Erectile Dysfunction. Where Do We Stand?
por: Thomas, Charalampos, et al.
Publicado: (2021) -
The Quality of Life and Economic Burden of Erectile Dysfunction
por: Elterman, Dean S, et al.
Publicado: (2021) -
Erectile Dysfunction Among HIV Patients Undergoing Highly Active Antiretroviral Therapy: Dyslipidemia as a Main Risk Factor
por: Romero-Velez, Gustavo, et al.
Publicado: (2014) -
Stem-cell therapy for erectile dysfunction
por: Albersen, Maarten, et al.
Publicado: (2013) -
Novel Emerging Therapies for Erectile Dysfunction
por: Kim, Soyeun, et al.
Publicado: (2021)